BRPI0819026B8 - método para produzir um gel aquoso de adapaleno e gel aquoso de adapaleno - Google Patents

método para produzir um gel aquoso de adapaleno e gel aquoso de adapaleno

Info

Publication number
BRPI0819026B8
BRPI0819026B8 BRPI0819026A BRPI0819026A BRPI0819026B8 BR PI0819026 B8 BRPI0819026 B8 BR PI0819026B8 BR PI0819026 A BRPI0819026 A BR PI0819026A BR PI0819026 A BRPI0819026 A BR PI0819026A BR PI0819026 B8 BRPI0819026 B8 BR PI0819026B8
Authority
BR
Brazil
Prior art keywords
aqueous
adapalene
producing
adapalene gel
gel
Prior art date
Application number
BRPI0819026A
Other languages
English (en)
Inventor
Ebel Maurice
Dugat Richard
Original Assignee
Galderma Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev
Publication of BRPI0819026A2 publication Critical patent/BRPI0819026A2/pt
Publication of BRPI0819026B1 publication Critical patent/BRPI0819026B1/pt
Publication of BRPI0819026B8 publication Critical patent/BRPI0819026B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

método para produzir em gel aquoso de adapaleno e gel aquoso de adapaleno. a presente invenção trata de um método para produzir um gel aquoso de adapaleno, método esse que compreende: preparar um meio gelificante a misturando água e propileno glicol e adicionando um agente gelificante; preparar um meio de adapaleno b dispersando o adapaleno em água, na presença de um tensoativo; adicionar o meio de adapaleno b ao meio gelificante a; e ajustar o ph a aproximadamente 4,7 - 5,3.
BRPI0819026A 2007-11-27 2008-11-27 método para produzir um gel aquoso de adapaleno e gel aquoso de adapaleno BRPI0819026B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US99661807P 2007-11-27 2007-11-27
EP07121665A EP2065032A1 (en) 2007-11-27 2007-11-27 A method for producing adapalene gels
PCT/EP2008/066339 WO2009068610A1 (en) 2007-11-27 2008-11-27 A method for producing adapalene gels

Publications (3)

Publication Number Publication Date
BRPI0819026A2 BRPI0819026A2 (pt) 2017-04-04
BRPI0819026B1 BRPI0819026B1 (pt) 2020-05-05
BRPI0819026B8 true BRPI0819026B8 (pt) 2021-05-25

Family

ID=39247232

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0819026A BRPI0819026B8 (pt) 2007-11-27 2008-11-27 método para produzir um gel aquoso de adapaleno e gel aquoso de adapaleno

Country Status (13)

Country Link
US (1) US8404220B2 (pt)
EP (3) EP2065032A1 (pt)
JP (2) JP5526035B2 (pt)
KR (1) KR101563379B1 (pt)
CN (2) CN101878022B (pt)
AR (1) AR071737A1 (pt)
AU (1) AU2008328764B2 (pt)
BR (1) BRPI0819026B8 (pt)
CA (1) CA2706379A1 (pt)
ES (2) ES2464455T3 (pt)
MX (1) MX2010005432A (pt)
RU (1) RU2476203C2 (pt)
WO (1) WO2009068610A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1684782T3 (en) 2003-10-03 2015-11-02 Thorn Bioscience Llc PROCEDURE FOR SYNCHRONIZING OVULATION FOR TEMPORARY REGULATED BREEDING WITHOUT BROWN DETECTION
FR2910320B1 (fr) 2006-12-21 2009-02-13 Galderma Res & Dev S N C Snc Emulsion comprenant au moins un retinoide et du peroxyde de benzole
FR2910321B1 (fr) 2006-12-21 2009-07-10 Galderma Res & Dev S N C Snc Gel creme comprenant au moins un retinoide et du peroxyde de benzole
ES2661240T3 (es) 2009-04-23 2018-03-28 Jbs United Animal Health Ii Llc Método y composición para sincronizar el momento de inseminación
FR2969492B1 (fr) * 2010-12-23 2013-07-05 Galderma Res & Dev Mousses dermatologiques obtenues a partir d'un gel ou d'une suspension contenant de l'adapalene
CN102274159A (zh) * 2011-07-12 2011-12-14 广东东阳光药业有限公司 一种经皮渗透给药的维甲酸类药物组合物及其制备方法
FR2991177B1 (fr) 2012-06-01 2014-12-19 Galderma Res & Dev Compositions topiques, contenant un retinoide, de type emulsion huile dans eau sans emulsionnant
CN103099775B (zh) * 2012-10-08 2014-12-31 天津金耀集团有限公司 阿达帕林凝胶
KR20150095715A (ko) 2012-11-28 2015-08-21 제이비에스 유나이티드 애니멀 헬스투 엘엘씨 미경산돈에서 수정 시간을 동기화하기 위한 방법
TW201625218A (zh) * 2014-04-18 2016-07-16 Ｊｂｓ聯合動物保健有限責任公司 製造含ｇｎｒｈ凝膠之方法
CN105411999A (zh) * 2015-11-23 2016-03-23 安徽新和成皖南药业有限公司 一种阿达帕林凝胶的制备方法
US9987239B1 (en) 2017-03-14 2018-06-05 Rey Ventures, LLC Pharmaceutical retinoid preparation for topical use
CN111759798A (zh) * 2017-12-21 2020-10-13 兆科（广州）眼科药物有限公司 一种凝胶制剂中阿达帕林的分散工艺
WO2019240290A1 (ja) * 2018-06-16 2019-12-19 ロート製薬株式会社 外用組成物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU85849A1 (fr) 1985-04-11 1986-11-05 Cird Derives benzonaphtaleniques,leur procede de preparation et leur application dans les domaines pharmaceutiques et cosmetiques
FR2636061B1 (fr) 1988-09-07 1990-11-09 Cird Procede de preparation de derives de l'adamantane-1
FR2833841B1 (fr) * 2001-12-21 2005-07-22 Galderma Res & Dev Gel comprenant au moins un retinoide et du peroxyde de benzoyle
US7820186B2 (en) * 2001-12-21 2010-10-26 Galderma Research & Development Gel composition for once-daily treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt
WO2003075908A1 (en) * 2002-03-12 2003-09-18 Galderma Research & Development, S.N.C. Use of adapalene for the treatment of dermatological disorders
EP1572176A2 (en) * 2002-12-12 2005-09-14 Galderma Research & Development, S.N.C. Aqueous-alcoholic depigmenting gel containing a phenolic derivative and a retinoid
FR2871377B1 (fr) * 2004-06-11 2007-08-24 Galderma Res & Dev Gel depigmentant hydroalcoolique comprenant du mequinol et de l'adapalene
KR20070091613A (ko) * 2004-11-08 2007-09-11 그렌마크 파머수티칼스 엘티디. 항여드름 화합물 및 항생제 화합물을 함유하는 국소적 제약조성물
MX2008003422A (es) * 2005-09-16 2008-03-27 Galderma Res & Dev Composiciones que comprenden al menos un derivado de acido naftoico y al menos un compuesto de tipo polimero de poliuretano o derivados del mismo, procesos de preparacion y composiciones que comprenden al menos un derivado de acido naftoico y al meno
US20080175810A1 (en) * 2007-01-22 2008-07-24 Jerry Zhang Topical compositions for cosmetic and pharmaceutical use

Also Published As

Publication number Publication date
JP2014101373A (ja) 2014-06-05
MX2010005432A (es) 2010-06-02
BRPI0819026B1 (pt) 2020-05-05
JP2011504912A (ja) 2011-02-17
AU2008328764A1 (en) 2009-06-04
ES2464455T3 (es) 2014-06-02
US8404220B2 (en) 2013-03-26
EP2460513B1 (en) 2021-07-21
KR20100098539A (ko) 2010-09-07
RU2476203C2 (ru) 2013-02-27
CN103830163A (zh) 2014-06-04
AR071737A1 (es) 2010-07-14
US20100280121A1 (en) 2010-11-04
ES2887225T3 (es) 2021-12-22
EP2460513A1 (en) 2012-06-06
EP2224906A1 (en) 2010-09-08
CN103830163B (zh) 2016-12-07
AU2008328764B2 (en) 2013-11-21
CA2706379A1 (en) 2009-06-04
EP2224906B1 (en) 2014-02-19
BRPI0819026A2 (pt) 2017-04-04
CN101878022A (zh) 2010-11-03
KR101563379B1 (ko) 2015-10-26
JP5526035B2 (ja) 2014-06-18
EP2065032A1 (en) 2009-06-03
CN101878022B (zh) 2014-02-19
WO2009068610A1 (en) 2009-06-04
RU2010126103A (ru) 2012-01-10

Similar Documents

Publication Publication Date Title
BRPI0819026B8 (pt) método para produzir um gel aquoso de adapaleno e gel aquoso de adapaleno
AR063429A1 (es) Anticuerpos anti- htnfalfa cristalinos
CL2007002342A1 (es) Proceso para producir pigmento blanco que comprende reaccionar acido fosforico, hidroxido de aluminio y aluminato de sodio, donde el pigmento comprende fosfato o polifosfato de aluminio amorfo; pigmento blanco; y mezcla fluida.
NZ612503A (en) Method for producing an aqueous stable chlorine dioxide solution
PE20130154A1 (es) Procedimiento para producir derivados de amina opticamente activos
CO6300911A2 (es) Composiciones agricolas de baja tasa de uso y metodos para su uso
BR112016002894A2 (pt) processo para a preparação de polióis poliéter/carbonato, poliol poliéter/carbonato e uso deste
BR112014005190A2 (pt) composições em microcápsula compreendendo gelificantes de di-amido ajustáveis por ph
AR070203A1 (es) Sistemas de geles no acuosos degradables
AR087720A1 (es) Proceso de remineralizacion de agua desalinizada y dulce dosificando una solucion de carbonato de calcio en agua blanda
GT201200196A (es) Método para realizar una composición antitranspirante anhidra líquida
BR112013014418A2 (pt) processo e fluido para o tratamento de uma formação que contém ilita
BR112012004952A2 (pt) processo para produzir ácido acético e dimetil éter usando um catalisador zeólito
AR065963A1 (es) Solucion acuosa de peroxido de hidrogeno, proceso para su preparacion y su uso
CL2011000157A1 (es) Emulsion de brea, que comprende brea dispersada en agua, y un agente emulsionante basado en acido graso, acido de colofonia; metodo para preparar la emulsion; y metodo para reducir polvo fugitivo.
AR088524A1 (es) Composicion descongelante, proceso de preparacion, conjunto de parte y uso
BRPI0800853A2 (pt) concentrado embalado, processo para preparaÇço de um concentrado embalado e uso de um concentrado embalado
AR088448A1 (es) Composicion para curtido ecologica
BR112015027187A2 (pt) processo de fabricação de uma composição antiperspirante aquosa e método de obtenção de um benefício de antiperspirância
CL2013002633A1 (es) Composicion de apresto que contiene un agente de apresto hidrofobico de papel y una poli(aminoamida) hidrofobicamente modificada, metodo para preparar una composicion de apresto, y metodo para apresto de papel.
MY162454A (en) Solid oxidized glutathione salt and method for producing same
CR11008A (es) Sales, composiciones liquidas acuosas que contienen sales de acido s-(+)- abscisico y metodos para su preparacion
BR112014018028A8 (pt) Processo para preparação de sílicas precipitadas
BR112013025916A2 (pt) método para produzir um produto de gesso
BR112017022395A2 (pt) método para preparação de um agente de direcionamento de estrutura, e, composição

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 05/05/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 27/11/2008 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 15A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2750 DE 19-09-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.